Phase II trial of methotrexate-FAM (m-FAM) in adenocarcinoma of unknown primary
Tài liệu tham khảo
Goldberg, 1986, 5-Fluorouracil, Adriamycin® and mitomycin in the treatment of adenocarcinoma of unknown primary, J Clin Oncol, 4, 395, 10.1200/JCO.1986.4.3.395
Cadman, 1979, Enhanced 5-fluorouracil nucleotide formation after methotrexate administration: explanation for drug synergism, Science, 205, 1135, 10.1126/science.472732
Benz, 1981, Modulation of 5-fluorouracil metabolism and cytotoxicity by anti-metabolic pretreatment in human colorectal adenocarcinoma HCT-8, Cancer Res, 41, 994
MacDonald, 1980, 5-Fluorouracil, doxorubicin and mitomycin (FAM) combination chemotherapy for advanced gastric cancer, Ann Intern Med, 93, 533, 10.7326/0003-4819-93-4-533
Nystrom, 1979, Identifying the primary site in metastatic cancer of unknown origin, JAMA, 241, 381, 10.1001/jama.1979.03290300023020
Moertel, 1972, Treatment of the patient with adenocarcinoma of unknown origin, Cancer, 30, 1469, 10.1002/1097-0142(197212)30:6<1469::AID-CNCR2820300609>3.0.CO;2-T
Holmes, 1970, Metastatic cancer of unknown primary site, Cancer, 26, 816, 10.1002/1097-0142(197010)26:4<816::AID-CNCR2820260413>3.0.CO;2-R
Didoklar, 1977, Metastatic carcinomas from occult primary tumors: a study of 254 patients, Ann Surg, 186, 625, 10.1097/00000658-197711000-00014
Indupalli, 1981, Adenocarcinoma of unknown primary origin: impact of chemotherapy on survival, South Med J, 74, 1431, 10.1097/00007611-198112000-00003
Pasterz, 1986, Prognostic factors in metastatic carcinoma of unknown primary, J Clin Oncol, 4, 1652, 10.1200/JCO.1986.4.11.1652
Klein, 1986, 5-Fluorouracil (5-FU), Adriamycin® (ADM), and methotrexate (MTX)—a combination protocol (FAMTX) for treatment of metastasized stomach cancer, 5, 84
Gewirtz, 1981, Preliminary report on the efficacy of sequential methotrexate and 5-fluorouracil in advanced breast cancer, Cancer, 47, 2552, 10.1002/1097-0142(19810601)47:11<2552::AID-CNCR2820471106>3.0.CO;2-Y
Ardalan, 1978, Tumor 5-fluorodeoxyuridylate concentration as a determinant of 5-fluorouracil response, Biochem Pharmacol, 27, 2009, 10.1016/0006-2952(78)90059-X
Maley, 1977, Pyrimidine antagonists, Vol. 5, 327